Adherence as a Predictor of the Development of Class-Specific Resistance Mutations: The Swiss HIV Cohort Study

V. von Wyl, T. Klimkait, S. Yerly, D. Nicca, H. Furrer, M. Cavassini, A. Calmy, E. Bernasconi, J. Böni, V. Aubert, H. Günthard, H. Bucher, T. Glass, and the Swiss HIV Cohort Study. PLOS ONE.Volume 8, Issue 10, October 2013, e77691, 11 pages. This email address is being protected from spambots. You need JavaScript enabled to view it.

Citation: “... Patients for this study were selected from the [Swiss HIV Cohort Study] SHCS, which is a nationwide observational study of HIV infected individuals in medical care in Switzerland. ... The genotypic drug resistance data stem from the SHCS drug resistance database, which is a central, anonymized collection of all genotypic drug resistance tests ever performed on SHCS enrolees by one of the four authorized laboratories in Switzerland ... The data are stored in SmartGene’s Integrated Data Network Services ...”